98 related articles for article (PubMed ID: 11563867)
1. Current methods of testing for human papillomavirus.
Davies P; Kornegay J; Iftner T
Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):677-700. PubMed ID: 11563867
[TBL] [Abstract][Full Text] [Related]
2. Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay.
Hsing AW; Burk RD; Liaw KL; Chen CJ; Zhang T; Schiffman M; Greer CE; You SL; Hsieh CY; Huang TW; Wu TC; O'Leary TJ; Seidman JD; Manos MM
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):483-4. PubMed ID: 8781747
[No Abstract] [Full Text] [Related]
3. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus detection: verification with cervical cytology.
Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a colorimetric PCR system for the detection and typing of human papillomaviruses.
Chouhy D; Gil LB; Nocito AL; Wojdyla D; Ornella L; Cittadini J; Gardiol D; Giri AA
Int J Mol Med; 2006 Nov; 18(5):995-1003. PubMed ID: 17016633
[TBL] [Abstract][Full Text] [Related]
6. New HPV test now recommended.
AIDS Patient Care STDS; 2003 Dec; 17(12):671-2. PubMed ID: 14748367
[No Abstract] [Full Text] [Related]
7. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.
Dong SM; Pai SI; Rha SH; Hildesheim A; Kurman RJ; Schwartz PE; Mortel R; McGowan L; Greenberg MD; Barnes WA; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):3-6. PubMed ID: 11815394
[TBL] [Abstract][Full Text] [Related]
9. Transitional cell metaplasia of the uterine cervix is related to human papillomavirus: molecular analysis in seven patients with cytohistologic correlation.
Ng WK; Cheung LK; Li AS; Cheung FM; Chow JC
Cancer; 2002 Aug; 96(4):250-8. PubMed ID: 12209668
[TBL] [Abstract][Full Text] [Related]
10. Primary screening for human papillomavirus infection.
Dillner J
Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):743-57. PubMed ID: 11563870
[TBL] [Abstract][Full Text] [Related]
11. Molecular methods for the detection of human papillomavirus infection.
Lörincz AT
Obstet Gynecol Clin North Am; 1996 Sep; 23(3):707-30. PubMed ID: 8869954
[TBL] [Abstract][Full Text] [Related]
12. [Medicine and money: detection of HPV DNA--what's the impediment?].
Miseta A
Orv Hetil; 2003 Dec; 144(52):2589-90. PubMed ID: 15005070
[No Abstract] [Full Text] [Related]
13. Human papillomavirus: emerging trends in detection and management.
Wright JD; Herzog TJ
Curr Womens Health Rep; 2002 Aug; 2(4):259-65. PubMed ID: 12150752
[TBL] [Abstract][Full Text] [Related]
14. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
15. New approach to human high-risk papillomavirus (HR-HPV) genotyping.
Weismanová E; Weismann P; Vizváryová M; Lehotská V; Krizanová O; Repiská V; Kausitz J
Neoplasma; 2002; 49(4):217-24. PubMed ID: 12382018
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic tests for HPV infection.
Chin-Hong PV; Klausner JD
MLO Med Lab Obs; 2004 Oct; 36(10):10-2, 14-6; quiz 18-9. PubMed ID: 15536803
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology.
de Cremoux P; Coste J; Sastre-Garau X; Thioux M; Bouillac C; Labbé S; Cartier I; Ziol M; Dosda A; Le Galès C; Molinié V; Vacher-Lavenu MC; Cochand-Priollet B; Vielh P; Magdelénat H;
Am J Clin Pathol; 2003 Oct; 120(4):492-9. PubMed ID: 14560561
[TBL] [Abstract][Full Text] [Related]
18. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of human papillomavirus (HPV) infections.
Molijn A; Kleter B; Quint W; van Doorn LJ
J Clin Virol; 2005 Mar; 32 Suppl 1():S43-51. PubMed ID: 15753011
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and cervical disease in adolescents.
Guido R
Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
